[Federal Register: February 8, 2008 (Volume 73, Number 27)]
[Page 7567-7568]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]



Food and Drug Administration

Risk Communication Advisory Committee; Notice of Meeting

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.


    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Risk Communication Advisory Committee
    General Function of the Committee: To provide advice and 
recommendations to the agency on effective risk communication.
    Date and Time: The meeting will be held on February 28, 2008, from 
8 a.m. to 5 p.m. and February 29, 2008, from 8 a.m. to 4 p.m.
    Location: Washington DC North/Gaithersburg Hilton, 620 Perry Pkwy., 
Gaithersburg, MD 20877, Salons A, B, C, and D.
    Contact Person: Lee L. Zwanziger, Office of the Commissioner, 
Office of Planning (HFP-60), Food and Drug Administration, 5600 Fishers 
Lane, rm.15-22, Rockville, MD, 20857, 301-827-2895, Fax: 301-827-5340, 
Food and Drug Administration, or FDA Advisory Committee Information 
Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 
8732112560. Please call the Information Line for up-to-date information 
on this meeting. A notice in the Federal Register about last minute 
modifications that affect a previously announced advisory committee 
meeting cannot always be published quickly enough to provide timely 
notice. Therefore, you should always check the agency's Web site and 
call the appropriate advisory committee hot line/phone line to learn 
about possible modifications before coming to the meeting.
    Agenda: On February 28, 2008, the committee will meet for the first 
time, for presentations and discussion of the relation of FDA's risk 
communication programs and FDA's responsibilities. On February 29, 
2008, the meeting will continue with presentations and discussion of 
FDA's proposed template for press releases announcing product recalls 
with a view to incorporating best practices of risk communication.
    FDA intends to make background material available to the public no 
later than 2 business days before the meeting. If FDA is unable to post 
the background

[[Page 7568]]

material on its Web site prior to the meeting, the background material 
will be made publicly available at the location of the advisory 
committee meeting, and the background material will be posted on FDA's 
Web site after the meeting. Background material is available at http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.fda.gov/ohrms/dockets/ac/acmenu.htm
, click on the year 2008 and 

scroll down to the appropriate advisory committee link.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person on or before 
February 20, 2008. Oral presentations from the public will be scheduled 
between approximately 1 p.m. and 2 p.m. on February 28th and 11:15 to 
12:15 on February 29th. Those desiring to make formal oral 
presentations should notify the contact person and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their presentation 
on or before February 11, 2008. Time allotted for each presentation may 
be limited. If the number of registrants requesting to speak is greater 
than can be reasonably accommodated during the scheduled open public 
hearing session, FDA may conduct a lottery to determine the speakers 
for the scheduled open public hearing session. The contact person will 
notify interested persons regarding their request to speak by February 
12, 2008.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Lee L. Zwanziger at 
least 7 days in advance of the meeting.
    FDA is committed to the orderly conduct of its advisory committee 
meetings. Please visit our Web site at http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.fda.gov/oc/advisory/default.htm
 for procedures on public conduct during advisory committee 

    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: February 3, 2008.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. 08-588 Filed 2-5-08; 3:58 pm]